New Delhi, Sept. 25 -- The Government's Production Linked Incentive (PLI) schemes are driving investment and strengthening domestic manufacturing across India's pharmaceutical and medical devices sectors, according to the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers.

Aligned with the Make in India and Atmanirbhar Bharat initiatives, three PLI schemes support manufacturing of critical pharmaceutical ingredients, high-value medicines and advanced medical devices, while reducing import dependence and promoting technology adoption.

The PLI Scheme for Pharmaceuticals, with a financial outlay of Rs.15,000 crore, aims to enhance manufacturing capabilities, increase investment and production, and promote high-value pharmac...